Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin + Cetuximab/Irinotecan in KRAS-Mutant Colorectal Cancer
NCT01281761Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of simvastatin in colorectal cancer (metastatic) (mCRC), sponsored by Samsung Medical Center. Started Nov 2010; status: completed.
02
Drugs
simvastatin
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01281761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281761.